Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal

被引:15
作者
Danekhu, Krisha [1 ,2 ]
Shrestha, Sunil [2 ,3 ]
Aryal, Sushant [4 ]
Shankar, P. Ravi [5 ]
机构
[1] Cogent Hlth Pvt Ltd, Lalitpur, Nepal
[2] Nepal Hlth Res & Innovat Fdn, Lalitpur, Nepal
[3] Nepal Canc Hosp & Res Ctr, Harisiddhi 44700, Lalitpur, Nepal
[4] Tribhuvan Univ, Universal Coll Med Sci, Rupandehi, Nepal
[5] Hlth City Univ, Gros Islet, St Lucia
关键词
adverse drug reaction reporting systems; health-care professionals' knowledge; Nepal; perception; pharmacovigilance; PHARMACISTS; ATTITUDES; THALIDOMIDE; AWARENESS;
D O I
10.1177/0018578719883796
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Underreporting of adverse drug reactions (ADRs) is common globally, and Nepal is not an exception to this. Health-care professionals (HCPs) play a vital role in reporting ADR during routine practice. Lack of knowledge and awareness about pharmacovigilance and reporting ADRs among HCPs may contribute to underreporting. Objective: The objective of this study was to evaluate the knowledge and perception of HCPs regarding ADR reporting and pharmacovigilance in a tertiary care teaching hospital in, Nepal. Methods: A descriptive cross-sectional study was conducted. A questionnaire was distributed to 215 HCPs (medical doctors, nurses, and pharmacists) between March and September 2018. Knowledge and perception regarding ADR reporting and pharmacovigilance were studied. Data were analyzed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp, Armonk, New York). Results: The HCPs included 75 medical doctors, 126 nurses, and 14 pharmacists. Majority of the participants were female (67%), and the majority of participants were not aware of pharmacovigilance. Among the participants, pharmacists were found to have better knowledge regarding pharmacovigilance. However, other HCPs (doctors and nurses) strongly agreed about the necessity of having adequate knowledge about pharmacovigilance. Out of 215, 57.7% agreed that the important benefit of reporting ADR was to identify safe drugs and improve patient safety. The main reasons for not reporting were - ADR reporting was not widely promoted by relevant authorities (47%), followed by not knowing where and how to report ADR (34.9%). However, other HCPs (doctors and nurses) strongly agreed about the necessity of having adequate knowledge about pharmacovigilance. Conclusions: The knowledge of HCPs on ADR reporting and pharmacovigilance was poor. Despite a low knowledge of ADR reporting and pharmacovigilance among HCPs, there was a positive perception that ADR reporting is necessary and ADR monitoring system should be established in the hospital. This study also highlights a need for future intervention studies focusing on educating HCPs about ADR and pharmacovigilance.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 52 条
[1]   Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia [J].
Abdel-Latif, Mohamed M. M. ;
Abdel-Wahab, Basel A. .
SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (02) :154-161
[2]   Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan [J].
Abu Hammour, Khawla ;
El-Dahiyat, Faris ;
Abu Farha, Rana .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2017, 23 (03) :608-613
[3]   Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance [J].
Almandil, Noor B. .
SAUDI MEDICAL JOURNAL, 2016, 37 (12) :1359-1364
[4]   Under-reporting of adverse drug reactions -: Estimate based on a spontaneous reporting scheme and a sentinel system [J].
Alvarez-Requejo, A ;
Carvajal, A ;
Bégaud, B ;
Moride, Y ;
Vega, T ;
Arias, LHM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (06) :483-488
[5]   The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective [J].
Anderson, Claire ;
Krska, Janet ;
Murphy, Elizabeth ;
Avery, Anthony .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) :806-822
[6]  
[Anonymous], 2006, SAFETY MED PUBLIC HL
[7]  
[Anonymous], 1975, REQ ADV REACT REP
[8]  
[Anonymous], INT J RISK SAF MED
[9]   Fatal adverse drug events: the paradox of drug treatment [J].
Buajordet, I ;
Ebbesen, J ;
Erikssen, J ;
Brors, O ;
Hilberg, T .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (04) :327-341
[10]  
Chhabra Kumar G, 2017, J Contemp Dent Pract, V18, P964